RaySearch Laboratories (Q1 Review): Below soft assumptions - Redeye
Bildkälla: Stockfoto

RaySearch Laboratories (Q1 Review): Below soft assumptions - Redeye

Softer sales, partly due to delays, impacted the quarter, but should point to a strong Q2. The new EBIT margin target underpins our forecast for 2028e, but we see room for upward adjustments during 2027. We reiterate our SEK365 base case.

Softer sales, partly due to delays, impacted the quarter, but should point to a strong Q2. The new EBIT margin target underpins our forecast for 2028e, but we see room for upward adjustments during 2027. We reiterate our SEK365 base case.
Börsvärldens nyhetsbrev